The European Commission has adopted a new Delegated Regulation intervening on the MDR (Regulation (EU) 2017/745) with a specific focus on so-called Well-Established Technologies (WET).
Since the MDR became fully applicable, one of the most discussed points has been the uniform approach required of all technologies, regardless of their level of innovation. In practice, even devices with decades of clinical use and a well-established safety profile have found themselves having to meet documentation and clinical requirements comparable to those of completely new technologies. The WET update goes in exactly the opposite direction: it introduces a more proportionate approach, recognising that not all technologies start from the same level of evidence and knowledge.
The Delegated Regulation seeks to clarify what'well established technology'means:
With the WET update, the principle that, for established technologies, greater reliance can be placed on existing data is reinforced. In practical terms, this translates into greater use of scientific literature and historical data, data from PMS and PMCF, and review, in justified cases, of the need for new clinical investigations.
To understand the context of this update and when and in what final form it will be adopted, it is useful to recall how the process of adopting a Delegated Regulation works in the European Union. The process follows a few key steps
Overall, a total time between 9 and 18 months can be estimated, from the preparatory phase to actual implementation.
We make it simple! Contact us: together we will find the simplest solution for your needs.